logo
OncTalk, LLC
OncTalk has moved to GRACE!.
Please migrate over and enjoy the new and
improved OncTalk through GRACE.
       
"As of April 30, 2008, all content from OncTalk will remain browsable and searchable, but no further content is being added to the post section or discussion forums. Post content has been moved to the website for GRACE (www.cancergrace.org). Please visit GRACE to provide your comments to posts and to initiate threads or add to the discussions in the forums on the GRACE site."

 

April 30, 2008


Email This Post
Print This Post

Biomarkers Predicting Clinical Benefits for BAC Patients Receiving Tarceva

  The second post of the article on tarceva for advanced BAC, based on a clinical trial from Memorial Sloan Kettering Cancer Center, focuses on biomarkers correlated with better and worse results with tarceva.  This post is available here on the GRACE website.



posted by Dr. West @ 10:11 pm link to this post

Comments are closed.

top of page Browse Complete Archives
Email This Post
Print This Post
About the Author:
Howard (Jack) West, MD
Dr. West serves as the Founder and Managing Member of OncTalk, LLC. He is a medical oncologist and Director of Medical Therapeutics for Thoracic Oncology at the Swedish Cancer Institute in Seattle, Washington.
Bio | C.V. | Contact



POLLS

Do you prefer to see generic names or trade names for drugs in our posts and comments?

View Results

Loading ... Loading ...

Disclaimer: The information provided at OncTalk is for informational purposes only. Howard West, MD is not providing medical advice, diagnosis or treatment and cannot replace the medical advice of your doctor or health care provider. (Full Disclaimer)
© 2006-07 OncTalk LLC. All rights reserved. Contact Webmaster




Disclaimer: The information provided at OncTalk is for informational purposes only. Howard West, MD is not providing medical advice, diagnosis or treatment and cannot replace the medical advice of your doctor or health care provider.